BRIEF

on Zomedica Corp. (NASDAQ:ZOM)

US Equestrian Names Zomedica’s PulseVet System as the Official Shock Wave Therapy of US Equestrian Team Veterinarians

Stock price chart of Zomedica Corp. (EBR:ZOM) showing fluctuations.

Zomedica Corp., a veterinary health company, announced that the United States Equestrian Federation (USEF) has named PulseVet as the Official Shock Wave Therapy Supplier for US Equestrian team veterinarians. USEF competes in a variety of international events, including the Olympics and Paralympics.

Bill Moroney, CEO of US Equestrian, expressed pride in the partnership, highlighting PulseVet's reputation in quality and innovation. Larry Heaton, CEO of Zomedica, emphasized the honor of supporting equine athletes heading to the Olympics.

PulseVet's device, known for its electro-hydraulic shock wave technology, provides non-invasive treatments to reduce inflammation, increase blood flow, and accelerate tissue development. Trudy Gage, Zomedica’s VP of Equine Sales, emphasized the shared commitment to equine care at all competition levels.

R. H.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Zomedica Corp. news